Literature DB >> 23458360

Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases.

Christian Sturesson1, Jan Nilsson, Sam Eriksson, Lidewij Spelt, Roland Andersson.   

Abstract

BACKGROUND: Chemotherapy before resection of colorectal metastases in the liver is extensively used and has been shown to induce histopathological changes in the liver parenchyma, although little is known about the effect of chemotherapy on liver regeneration. The aim of this study was to determine if pre-operative chemotherapy influences the regenerated liver volume after a major liver resection. PATIENTS AND METHODS: This retrospective cohort study included 74 patients subjected to a major liver resection for colorectal metastases. Patients were divided into two groups depending on whether they had been treated with chemotherapy less than 3 months before surgery or not. Liver volumes were measured before and 1 year after resection.
RESULTS: Pre-operative chemotherapy reduced volumetric liver regeneration (83 ± 2% versus 91 ± 2%; P = 0.007) as compared with patients without chemotherapy. There was a linear correlation between regenerated volume and time interval between the end of chemotherapy to resection (P = 0.031).
CONCLUSIONS: Pre-operative chemotherapy in patients with colorectal liver metastases negatively affects volume regeneration after a partial hepatectomy. The time interval between chemotherapy and surgery determines the impact of these affects.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23458360      PMCID: PMC3731588          DOI: 10.1111/hpb.12040

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  48 in total

1.  Liver regeneration after major hepatectomy for biliary cancer.

Authors:  M Nagino; M Ando; J Kamiya; K Uesaka; T Sano; Y Nimura
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

2.  Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal.

Authors:  R Adam; E Avisar; A Ariche; S Giachetti; D Azoulay; D Castaing; F Kunstlinger; F Levi; F Bismuth
Journal:  Ann Surg Oncol       Date:  2001-05       Impact factor: 5.344

3.  Body surface area and body weight predict total liver volume in Western adults.

Authors:  Jean-Nicolas Vauthey; Eddie K Abdalla; Dorota A Doherty; Philippe Gertsch; Marc J Fenstermacher; Evelyne M Loyer; Jan Lerut; Roland Materne; Xuemei Wang; Arthur Encarnacion; Delise Herron; Christian Mathey; Giovanni Ferrari; Chuslip Charnsangavej; Kim-Anh Do; Alban Denys
Journal:  Liver Transpl       Date:  2002-03       Impact factor: 5.799

4.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

5.  Liver regeneration and surgical outcome in donors of right-lobe liver grafts.

Authors:  Elizabeth A Pomfret; James J Pomposelli; Fredric D Gordon; Nazli Erbay; Lori Lyn Price; W David Lewis; Roger L Jenkins
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

6.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  L Rubbia-Brandt; V Audard; P Sartoretti; A D Roth; C Brezault; M Le Charpentier; B Dousset; P Morel; O Soubrane; S Chaussade; G Mentha; B Terris
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

7.  Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

Authors:  C Pozzo; M Basso; A Cassano; M Quirino; G Schinzari; N Trigila; M Vellone; F Giuliante; G Nuzzo; C Barone
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

8.  Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats.

Authors:  P D Hockings; K K Changani; N Saeed; D G Reid; J Birmingham; P O'Brien; J Osborne; C N Toseland; R E Buckingham
Journal:  Diabetes Obes Metab       Date:  2003-07       Impact factor: 6.577

9.  Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

Authors:  Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

10.  Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver.

Authors:  K Tanaka; R Adam; H Shimada; D Azoulay; F Lévi; H Bismuth
Journal:  Br J Surg       Date:  2003-08       Impact factor: 6.939

View more
  8 in total

1.  Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases.

Authors:  Lidewij Spelt; Ernesto Sparrelid; Bengt Isaksson; Roland G Andersson; Christian Sturesson
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

2.  Incisional hernia after open resections for colorectal liver metastases - incidence and risk factors.

Authors:  Jan H Nilsson; Peter Strandberg Holka; Christian Sturesson
Journal:  HPB (Oxford)       Date:  2016-03-10       Impact factor: 3.647

3.  The Impact of Advancing Age on Recurrence and Survival Following Major Hepatectomy for Colorectal Liver Metastases.

Authors:  Richard Bell; Sanjay Pandanaboyana; Saira Nisar; Vivek Upasani; Giles Toogood; J Peter Lodge; K Raj Prasad
Journal:  J Gastrointest Surg       Date:  2016-10-21       Impact factor: 3.452

4.  Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy.

Authors:  Kiyohiko Omichi; Suguru Yamashita; Jordan M Cloyd; Junichi Shindoh; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Jean-Nicolas Vauthey; Ching-Wei D Tzeng
Journal:  J Gastrointest Surg       Date:  2017-06-05       Impact factor: 3.452

5.  The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy.

Authors:  Stéphanie Truant; Clio Baillet; Viviane Gnemmi; Maxence Fulbert; Anthony Turpin; Sabrina Dardenne; Emmanuelle Leteurtre; Mehdi El Amrani; Sébastien Dharancy; Laurent Dubuquoy; Damien Huglo; Christophe Chesné; François-René Pruvot
Journal:  Ann Surg Oncol       Date:  2020-08-24       Impact factor: 5.344

Review 6.  Laparoscopic liver resection: wedge resections to living donor hepatectomy, are we heading in the right direction?

Authors:  P Thomas Cherian; Ashish Kumar Mishra; Palaniappen Kumar; Vijayant Kumar Sachan; Anand Bharathan; Gadiyaram Srikanth; Baiju Senadhipan; Mohamad S Rela
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

7.  Perioperative liver and spleen elastography in patients without chronic liver disease.

Authors:  Sam Eriksson; Hanna Borsiin; Carl-Fredrik Öberg; Hannes Brange; Zoran Mijovic; Christian Sturesson
Journal:  World J Gastrointest Surg       Date:  2018-02-27

8.  Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.

Authors:  Damian J Mole; Jonathan A Fallowfield; Ahmed E Sherif; Timothy Kendall; Scott Semple; Matt Kelly; Gerard Ridgway; John J Connell; John McGonigle; Rajarshi Banerjee; J Michael Brady; Xiaozhong Zheng; Michael Hughes; Lucile Neyton; Joanne McClintock; Garry Tucker; Hilary Nailon; Dilip Patel; Anthony Wackett; Michelle Steven; Fenella Welsh; Myrddin Rees
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.